| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 47.57B | 47.05B | 37.07B | 31.28B | 29.01B | 27.01B |
| Gross Profit | 17.94B | 17.72B | 14.34B | 12.04B | 10.84B | 10.58B |
| EBITDA | 3.04B | 3.17B | 3.15B | 2.38B | 2.09B | 1.29B |
| Net Income | 1.81B | 2.06B | 1.97B | 1.43B | 1.56B | 199.00M |
Balance Sheet | ||||||
| Total Assets | 27.27B | 26.22B | 24.25B | 19.37B | 18.86B | 16.90B |
| Cash, Cash Equivalents and Short-Term Investments | 8.25B | 9.63B | 10.57B | 10.37B | 10.36B | 8.80B |
| Total Debt | 1.92B | 1.99B | 2.51B | 104.00M | 506.00M | 909.00M |
| Total Liabilities | 9.63B | 8.99B | 9.32B | 5.09B | 5.95B | 5.73B |
| Stockholders Equity | 16.43B | 16.05B | 13.98B | 13.11B | 11.73B | 10.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 743.00M | 2.28B | 475.00M | 2.13B | 1.36B |
| Operating Cash Flow | 0.00 | 1.22B | 2.60B | 649.00M | 2.31B | 1.47B |
| Investing Cash Flow | 0.00 | -1.43B | -1.33B | -206.00M | -188.00M | -126.00M |
| Financing Cash Flow | 0.00 | -589.00M | -1.07B | -507.00M | -377.00M | 372.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥28.07B | 8.12 | ― | 3.77% | 7.88% | -5.92% | |
65 Neutral | ¥42.82B | 9.40 | ― | 2.19% | 17.90% | 14.14% | |
65 Neutral | ¥194.53B | 27.65 | ― | 0.64% | 57.01% | 91.03% | |
64 Neutral | ¥46.19B | 32.42 | ― | 0.26% | 15.30% | -15.97% | |
64 Neutral | ¥32.76B | 11.19 | ― | 1.73% | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥26.08B | 3.19 | ― | 0.95% | 4.14% | ― |